Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenon
Naomi F. Rothfield(University of Connecticut), Fredrick M. Wigey, David H. Collier(Amgen (United States)), Janet Pope(St Joseph's Health Care), Maureen D. Mayes(The University of Texas Health Science Center), J. J. F. Belch(Ninewells Hospital), Richard W. Martin(Grand Rapids Community College), Lee Shapiro(Albany Medical Center Hospital), Sangeeta Sule(Johns Hopkins University), Mary Ellen Csuka(Medical College of Wisconsin), Bashar Kahaleh(University of Toledo), David Fiorentino(Stanford University), Virginia Steen(Georgetown University), Ariane L. Herrick(University of Salford), Vivien Hsu(Rutgers, The State University of New Jersey), Barry L. Gruber(State University of New York), Murray Baron(McGill University), Nadera Sweiss(University of Illinois Chicago), Robert W. Simms(Dartmouth–Hitchcock Medical Center), A Scheja(Ospedali Riuniti Umberto I), Christopher P. Denton(The Royal Free Hospital), Edwin Smith(Medical University of South Carolina), Joseph C. Shanahan(Duke University), Paul Emery, Leland W.K. Chung(VA Palo Alto Health Care System)
Lund University Publications (Lund University)
January 1, 2008
Cited by 1
Related Papers
The 1982 revised criteria for the classification of systemic lupus erythematosus
|Arthritis & Rheumatism|1982|14.6k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
|New England Journal of Medicine|2000|1.8k